X-Chem, a company specializing in drug discovery services, has proudly announced a significant milestone in drug discovery, marking the successful advancement of a development candidate by one of its partners. Relay Therapeutics, a forefront player in innovative drug discovery methodologies, harnessed X-Chem's DNA-Encoded Library (DEL) platform for hit finding purposes, aiming to identify molecules with distinct pharmacological properties. The outcome of this collaboration produced a promising molecule that has now transitioned into a development candidate. This achievement signifies a key milestone as outlined in the partnership agreement between the two companies, marking progress in the ongoing evaluation process.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!